Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06172491 · ClinicalTrials.gov registry record

Automating Delirium Severity in the ICU

A clinical trial of Delirium and Encephalopathy, sponsored by Mayo Clinic.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT06172491 is a study of Delirium and Encephalopathy that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 400 participants, below the 881-participant average among 62 other Delirium trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06172491, a study of Delirium and Encephalopathy, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to develop a passive digital marker (PDM) for delirium severity and examine its performance in comparison to validated delirium severity tools in ICU patients \>50 years of age. The main questions it aims to answer are: * Is the trained convolutional neural network able to reliably measure delirium severity. * Is the Passive Digital Marker able to accurately measure delirium severity * Is the Passive Digital Marker acceptable and usable by frontline ICU nurse clinicians, patients, and their identified proxies (i.e., caregivers). Participants will: * Study participation involves a video camera recording you 24 hours per day while you are a patient in the Intensive Care Unit (ICU). * Study staff will visit you 4 times each day you are in the ICU. You will be asked questions each time they visit to train the digital marker and see differences between assessments and camera data.

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-01-15
Est. Completion 2026-12-18

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06172491

The ClinicalTrials.gov registry entry for NCT06172491 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 881-participant average among 62 other Delirium trials with a reported enrollment target (55% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Delirium appearing as the primary indexed condition, and to 0 interventions.

NCT06172491 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06172491 about?

NCT06172491 is a clinical study titled "Automating Delirium Severity in the ICU". The goal of this observational study is to develop a passive digital marker (PDM) for delirium severity and examine its performance in comparison to validated delirium severity tools in ICU patients \>50 years of age. The main questions it aims to answer are: * Is the trained convolutional neural ...

What is the current status of trial NCT06172491?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2023-01-15. Estimated completion is 2026-12-18.

What conditions does trial NCT06172491 study?

This clinical trial studies the following conditions: Delirium, Encephalopathy, Intensive Care Unit Delirium.

Who is sponsoring clinical trial NCT06172491?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06172491 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Delirium

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.